Patrick Christmas

(Mr. Patrick Christmas II)

Currently holds a position at Amag Pharma Usa Inc

Positions
Position Company Period
Vice President, General Counsel Amag Pharma Usa Inc June 1, 2011 -
Senior Vice President, General Counsel Regenxbio Inc Aug. 1, 2016 - Dec. 31, 2019
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Total value Details
2021-02-17 2021-02-12
US Regenxbio Inc (RGNX)
PS Planned sale
4,701 -22.3%
49.08
230,725 USD 		4,701 -22.3% 49.08 230,725 USD
2021-02-10 2021-02-08
US Regenxbio Inc (RGNX)
PS Planned sale
1,300 -7.4%
49.11
63,843 USD 		1,300 -7.4% 49.11 63,843 USD
2021-02-04 2021-02-02
US Regenxbio Inc (RGNX)
PS Planned sale
500 -3.0%
45.13
22,565 USD 		500 -3.0% 45.13 22,565 USD
2021-02-04 2021-02-02
US Regenxbio Inc (RGNX)
PS Planned sale
9,500 -36.0%
44.77
425,315 USD 		9,500 -36.0% 44.77 425,315 USD
2021-01-12 2021-01-12
US Regenxbio Inc (RGNX)
PS Planned sale
1,378 -7.8%
49.15
67,729 USD 		1,378 -7.8% 49.15 67,729 USD
2021-01-12 2021-01-11
US Regenxbio Inc (RGNX)
PS Planned sale
10,122 -38.2%
49.08
496,788 USD 		10,122 -38.2% 49.08 496,788 USD
2021-01-12 2021-01-08
US Regenxbio Inc (RGNX)
PS Planned sale
1,320 -7.5%
48.13
63,532 USD 		1,320 -7.5% 48.13 63,532 USD
2021-01-12 2021-01-08
US Regenxbio Inc (RGNX)
PS Planned sale
4,062 -18.7%
47.42
192,620 USD 		4,062 -18.7% 47.42 192,620 USD
2021-01-12 2021-01-08
US Regenxbio Inc (RGNX)
PS Planned sale
4,618 -17.5%
46.43
214,414 USD 		4,618 -17.5% 46.43 214,414 USD
2019-09-16 2019-09-12
US Regenxbio Inc (RGNX)
PS Planned sale
5,486 -68.1%
42.00
230,412 USD 		5,486 -68.1% 42.00 230,412 USD
2019-07-22 2019-07-19
US Regenxbio Inc (RGNX)
PS Planned sale
4,900 -61.6%
50.03
245,147 USD 		4,900 -61.6% 50.03 245,147 USD
2019-07-22 2019-07-18
US Regenxbio Inc (RGNX)
PS Planned sale
100 -3.2%
50.00
5,000 USD 		100 -3.2% 50.00 5,000 USD
2019-06-20 2019-06-18
US Regenxbio Inc (RGNX)
PS Planned sale
100 -3.2%
54.75
5,475 USD 		100 -3.2% 54.75 5,475 USD
2019-06-20 2019-06-18
US Regenxbio Inc (RGNX)
PS Planned sale
1,934 -38.4%
53.29
103,063 USD 		1,934 -38.4% 53.29 103,063 USD
2019-06-20 2019-06-18
US Regenxbio Inc (RGNX)
PS Planned sale
2,966 -37.0%
52.74
156,427 USD 		2,966 -37.0% 52.74 156,427 USD
2019-04-22 2019-04-18
US Regenxbio Inc (RGNX)
PS Planned sale
100 -3.2%
55.50
5,550 USD 		100 -3.2% 55.50 5,550 USD
2019-04-22 2019-04-18
US Regenxbio Inc (RGNX)
PS Planned sale
885 -22.2%
54.66
48,374 USD 		885 -22.2% 54.66 48,374 USD
2019-04-22 2019-04-18
US Regenxbio Inc (RGNX)
PS Planned sale
1,115 -21.8%
53.67
59,842 USD 		1,115 -21.8% 53.67 59,842 USD
2019-04-22 2019-04-18
US Regenxbio Inc (RGNX)
PS Planned sale
2,900 -36.2%
52.55
152,395 USD 		2,900 -36.2% 52.55 152,395 USD